Start with an end in mind
Should our products be patient-focused from the start, or should we be more mindful of milestones at the outset?
FACILITATED BY
JESÚS ZURDO | Global Head Cell, Gene Therapy & Bioproduction | Horizon Discovery
PANELLISTS INCLUDE
PAT FURLONG | Founding President & Chief Executive Officer | Parent Project Muscular Dystrophy
MIKE FRODSHAM | Chief Technical Officer | QuayPharma
ALEX HAMILTON | Partner | Syncona Investment Management
STEVE McCONCHIE| Chief Executive Officer | Aptus Clinical
TIM LUKER | Vice President Emerging Technology and Innovation| Eli Lilly
CHRISTIAN JONES | Chief Commercial Officer | Nanoform